Page last updated: 2024-08-24

triazoles and fluoxetine

triazoles has been researched along with fluoxetine in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's18 (48.65)18.2507
2000's15 (40.54)29.6817
2010's4 (10.81)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ieni, JR; Knight, DL; Nemeroff, CB; Owens, MJ; Winders, K1
Anton, SF; Revicki, DA1
Preskorn, SH1
Kaplita, SB; Marcus, RN; Roberts, DL; Robinson, DS; Seminara, JA; Smith, JM; Stringfellow, JC1
Castañeda, R; Levy, R; Sussman, N; Westreich, LM1
Brown, RE; Culpepper, L; Gonzales, J; Hales, RE; Keller, MB; Revicki, DA1
Möller, HJ; Volz, HP1
Armitage, R; Cole, D; Rush, AJ; Yonkers, K1
Albala, BJ; Erman, MK; Gillin, JC; Rapaport, M; Winokur, A1
Benazzi, F1
Albala, BJ; Armitage, R; Erman, MK; Fleming, JB; Gillin, JC; Kaplita, SB; McQuade, RD; Moldofsky, H; Montplaisir, J; Rush, AJ; Vogel, GW; Winokur, A; Yonkers, KA1
Richelson, E1
Anton, SF; Bakish, D; Brown, RE; Feeny, D; Palmer, W; Revicki, DA; Rosser, WW1
Benfield, P; Wilde, MI1
Thase, ME1
Churchill, E; Davidson, JR; Meltzer-Brody, S1
Smith, DL; Wenegrat, BG1
Davidson, JR1
Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL1
Jurima-Romet, M; Neigh, S; Wright, M1
Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL1
Ferguson, JM1
Baruch, Y; Chelben, J; Lustig, M; Strous, RD1
Keller, MB1
Alfaro, CL; Ereshefsky, L; Lam, YW; Miller, M1
Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L1
Boot, JR; Broadmore, RJ; Cooper, J; Eyre, TA; Mitchell, SN; Pullar, IA; Sanger, GJ; Wedley, S1
Albert, PR; Bakish, D; Du, L; Hrdina, P; Lemonde, S1
Martényi, F1
Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH1
Papakostas, GI; Shelton, RC1
Kelly, BD1
Contento Salcedo, AM; Muñoz Fernández, L; Rodríguez-Flores, J1
Dalla, C; Kafetzopoulos, V; Kokras, N; Mavridis, T; Pastromas, N; Porto, TH1
Fernández-Guasti, A; García-Cárdenas, N; Gómez-Quintanar, BN; Olvera-Hernández, S1
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X1
Chai, HH; Chen, GZ; Chen, WX; Chen, YS; Fu, XC; Guo, YW; Li, SP; Ma, L; Song, MY; Sun, HT; Tan, MX1

Reviews

11 review(s) available for triazoles and fluoxetine

ArticleYear
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
    The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6

    Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride

1995
The safety profile of nefazodone.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Mixed Function Oxygenases; Piperazines; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles; Weight Gain

1996
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
    Drugs, 1996, Volume: 52, Issue:5

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1996
Pharmacokinetic interactions of antidepressants.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 10

    Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1998
Fluoxetine. A pharmacoeconomic review of its use in depression.
    PharmacoEconomics, 1998, Volume: 13, Issue:5 Pt 1

    Topics: Antidepressive Agents, Tricyclic; Depression; Fluoxetine; Health Care Costs; Humans; Piperazines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Triazoles

1998
Antidepressant treatment of the depressed patient with insomnia.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 17

    Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

1999
Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 5

    Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Fluoxetine; Follow-Up Studies; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles

2000
The effects of antidepressants on sexual functioning in depressed patients: a review.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 3

    Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Single-Blind Method; Triazoles

2001
[Three paradigms in the treatment of posttraumatic stress disorder].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2005, Volume: 7, Issue:1

    Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Combat Disorders; Controlled Clinical Trials as Topic; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, Acute; Triazoles

2005
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
    Acta psychiatrica Scandinavica, 2008, Volume: 117, Issue:4

    Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles

2008
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Lancet (London, England), 2016, Aug-27, Volume: 388, Issue:10047

    Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

2016

Trials

6 trial(s) available for triazoles and fluoxetine

ArticleYear
A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Outpatients; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sleep, REM; Triazoles

1997
A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:5

    Topics: Adult; Affect; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Wake Disorders; Treatment Outcome; Triazoles

1997
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
    Biological psychiatry, 1998, Jul-01, Volume: 44, Issue:1

    Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Circadian Rhythm; Comorbidity; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Triazoles; Wakefulness

1998
Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder.
    Psychiatry research, 1999, Oct-18, Volume: 88, Issue:1

    Topics: Adult; Antidepressive Agents; Cohort Studies; Combat Disorders; Disasters; Female; Fluoxetine; Fluvoxamine; Humans; Lamotrigine; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Rape; Reproducibility of Results; Stress Disorders, Post-Traumatic; Triazines; Triazoles

1999
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:11

    Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Ketoconazole; Male; Midazolam; Piperazines; Triazoles

2003
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride

2004

Other Studies

20 other study(ies) available for triazoles and fluoxetine

ArticleYear
The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
    Life sciences, 1995, Volume: 57, Issue:24

    Topics: Animals; Antidepressive Agents; Carrier Proteins; Cerebral Cortex; Dose-Response Relationship, Drug; Fluoxetine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; p-Chloroamphetamine; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Triazoles

1995
The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
    Psychopharmacology bulletin, 1995, Volume: 31, Issue:2

    Topics: Antidepressive Agents; Cost-Benefit Analysis; Decision Support Techniques; Economics, Pharmaceutical; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Models, Economic; Piperazines; Treatment Outcome; Triazoles

1995
Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Piperazines; Recurrence; Serotonin Agents; Substance-Related Disorders; Triazoles; Venlafaxine Hydrochloride

1996
Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:2

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Depressive Disorder; Drug Costs; Fluoxetine; Health Care Costs; Health Policy; Health Services; Humans; Imipramine; Managed Care Programs; Patient Compliance; Piperazines; Probability; Quality-Adjusted Life Years; Treatment Failure; Treatment Outcome; Triazoles

1997
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
    Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:2

    Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride

1997
Modelling the cost effectiveness of antidepressant treatment in primary care.
    PharmacoEconomics, 1995, Volume: 8, Issue:6

    Topics: Antidepressive Agents; Decision Support Techniques; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Markov Chains; Models, Economic; Piperazines; Primary Health Care; Quality-Adjusted Life Years; Sensitivity and Specificity; Triazoles

1995
A case report of serotonin syndrome associated with combined nefazodone and fluoxetine.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Triazoles

2000
Newer antidepressants: a comparison of tolerability in general practice.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 1999, Volume: 49, Issue:448

    Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride

1999
Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
    British journal of clinical pharmacology, 1998, Volume: 45, Issue:3

    Topics: Alkylation; Antidepressive Agents, Second-Generation; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Histamine H1 Antagonists; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Piperazines; Sertraline; Terfenadine; Triazoles

1998
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:10

    Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles

2000
Remission of SSRI-induced akathisia after switch to nefazodone.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:7

    Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles

2001
Long-term treatment of recurrent and chronic depression.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 24

    Topics: Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost of Illness; Depressive Disorder; Disability Evaluation; Drug Administration Schedule; Fluoxetine; Humans; Piperazines; Placebos; Recurrence; Treatment Outcome; Triazoles

2001
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
    European journal of pharmacology, 2004, Jun-16, Volume: 493, Issue:1-3

    Topics: Animals; Autoreceptors; Cerebral Cortex; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Guinea Pigs; Hypothalamus; Indoles; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Piperidines; Piperidones; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Presynaptic; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Spiro Compounds; Subcellular Fractions; Triazoles; Tritium; United Kingdom

2004
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Alleles; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzimidazoles; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Pindolol; Piperazines; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Triazoles

2004
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
    The journal of sexual medicine, 2008, Volume: 5, Issue:2

    Topics: Antidepressive Agents; Coitus; Data Interpretation, Statistical; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Piperazines; Reaction Time; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sexual Dysfunction, Physiological; Treatment Outcome; Triazoles

2008
Do new-generation antidepressants work?
    Irish medical journal, 2008, Volume: 101, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

2008
Rapid quantitative analysis of letrozole, fluoxetine and their metabolites in biological and environmental samples by MEKC.
    Electrophoresis, 2009, Volume: 30, Issue:4

    Topics: Chromatography, Micellar Electrokinetic Capillary; Female; Fluoxetine; Humans; Hydrogen-Ion Concentration; Letrozole; Methanol; Nitriles; Reproducibility of Results; Saliva; Sensitivity and Specificity; Solid Phase Extraction; Temperature; Triazoles; Water Pollutants, Chemical; Water Supply

2009
Acute but not sustained aromatase inhibition displays antidepressant properties.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:8

    Topics: Animals; Antidepressive Agents; Aromatase Inhibitors; Drug Administration Schedule; Estradiol; Female; Fluoxetine; Immobility Response, Tonic; Letrozole; Nitriles; Progesterone; Rats; Testosterone; Triazoles

2014
Male rats with same sex preference show high experimental anxiety and lack of anxiogenic-like effect of fluoxetine in the plus maze test.
    Pharmacology, biochemistry, and behavior, 2015, Volume: 135

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Enzyme Inhibitors; Exploratory Behavior; Female; Fluoxetine; Homosexuality, Male; Letrozole; Male; Motor Activity; Nitriles; Rats; Rats, Wistar; Sex Characteristics; Triazoles

2015
The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:8

    Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Brain-Derived Neurotrophic Factor; Chemokine CXCL1; Depression; Fluoxetine; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Phenylurea Compounds; Receptors, Interleukin-8B; Stress, Psychological; Thiazoles; Triazoles; Urea

2019